Panel Discussion – Mast Cell Tumor Management

Small Animals


Panel Discussion
Venue: On-Demand Panel Discussion
Contact Hours: 3 Hours
Course Language: English
Price:
  • Net price, no tax will be added*
  • Choose currency at checkout
ATTENDEE TYPE LECTURES ONLY LECTURES & PRACTICAL SESSIONS
Qualified Vet USD 95.00 -
Veterinary Student USD 40.00 -
Intern/Resident (Requires Proof of Status) USD 75.00 -
Vet. Nurse / Vet. Technician USD 75.00 -
Sponsors:

* VAT (= MWST/MOMS/SALES TAX) will only be added for certain UK vets attending courses abroad and for all attendees when attending courses in the UK.

 
Register 

Panel Discussion - Mast Cell Tumor Management 

 

 

Panelists:         Cheryl London   DVM, PhD, DACVIM- Cummings School of Vet. Medicine at Tufts University,  USA
                               Bernard Séguin   DVM, MS Diplomate ACVS  - Colorado State University, USA
                               Barbara Kaser-Hotz  Dr.med.vet. DACVR, DECVDI  - AOI Animal Oncology and Imaging Center,
                               Switzerland

Moderator:    James Elliott   BVM&S, CertSAM, DECVIM-CA (Oncology), DACVR (RO),
                               MRCVS - Southfields Veterinary Specialists, UK 

  

PANEL DISCUSSION DESCRIPTION

Mast Cell Tumours (MCTs) are one of the most common malignant tumours dealt with in veterinary practice. They are the masters of disguise and exhibit a marked variation in biologic behaviour, from simple cure with surgery alone through to widespread metastasis. Multiple grading schemes, staging tests and prognostic factors have been described, and it can often be difficult for veterinarians to know which of these may be the most useful. The requirement for multi-modality therapy with a combination of surgery, radiation therapy and cytotoxic therapy is required for many patients and there are new drugs available to treat selected patients with MCTs.

Join us for this interactive panel discussion with a team of world-renowned  multidisciplinary experts in the field of veterinary oncology and MCTs, where we will discuss the grading, staging, prognostic factors and various therapies available for the treatment of MCT patients. Many of these subjects are still very controversial, and so a myriad of opinions from various specialists will be really interesting.  Attendees will have plenty of opportunity to ask questions and make comments. 

 

 

Panel Discussion Registration Process:     Once you have registered and upon payment, you will receive the link to access the on-demand recording for a period of 8 weeks. If you wish to receive a Certificate of Attendance after having viewed the webinar, please get in touch with us and we will send it to you electronically.

  • VetPD

    Cheryl London
    DVM, PhD, DACVIM

    United States

    American Specialist in Veterinary Internal Medicine
    More Info

    Cheryl London, DVM, PhD, ACVIM (Oncology) is a Research Professor at Cummings School of Veterinary Medicine at Tufts University and the Molecular Oncology Research Institute at Tufts Medical Center. She has an active laboratory research program centered on comparative and translational oncology and is involved in the training of graduate students and postdoctoral fellows. She has recently joined the Clinical Trials Office at Cummings School to expand operations and enhance capacity and breadth of trials performed in client owned animals. Dr. London is also an Associate Faculty Professor at the Ohio State University College of Veterinary Medicine (OSU CVM) where she remains Director of the Clinical Trials Office at the CVM and Director of Translational Therapeutics at the Center for Clinical and Translational Sciences, OSU College of Medicine. Prior to her time at OSU, she was an Assistant Professor in the Department of Surgical and Radiological Sciences at the University of California, Davis.

    Dr. London earned her DVM at Cummings School, completed her Residency in Medical Oncology at the University of Wisconsin-Madison and received her PhD in Immunology at Harvard University, where she was also a postdoctoral fellow in the Department of Pathology.

    Full details
  • VetPD

    Bernard Séguin
    DVM, MS, Dipl.ACVS

    Canada

    American Specialist in Veterinary Surgery
    More Info

    Dr. Séguin obtained his DVM from the University of Montréal. He performed a small animal internship at the University of Illinois. He was in small animal general private practice before completing a Master’s of Science and Small Animal Surgery Residency at Washington State University. He then went on to fulfill his Fellowship in Surgical Oncology at Colorado State University. He was on Faculty at the University of California, Davis, and Oregon State University, and was a full Professor of Surgical Oncology at the Flint Animal Cancer Center, Colorado State University. He has lectured nationally and internationally and has authored numerous scientific articles and book chapters. Dr. Séguin is the co-editor of the textbook Veterinary Surgical Oncology, now in its second edition. He is a specialist in veterinary surgery (Diplomate of the American College of Veterinary Surgeons) and an ACVS Founding Fellow of Surgical Oncology and an ACVS Founding Fellow of Oral and Maxillofacial Surgery.   Dr. Séguin has joined the Central Victoria Veterinary Hospital as a Veterinary Specialist in Surgical Oncology and Surgery.

    Full details
  • VetPD

    Barbara Kaser-Hotz
    Dr.med.vet. DACVR, DECVDI

    Switzerland

    American Specialist in Veterinary Radiology, European Specialist in Veterinary Diagnostic Imaging
    More Info

    Barbara qualified from the University of Bern, Switzerland, in 1984 and after working in a large animal practice and the equine clinic of the University in Bern, went on to perform a residency in radiology at the University of Pennsylvania and Colorado State University. She became a Diplomate of the American College of Veterinary Radiology in 1992. Back in Switzerland she worked at the University of Zurich and the Paul Scherrer Institute, where she was involved in building up radiation oncology, both as a clinical subspecialty and as a research opportunity. In 1994 she became board certified in Radiation Oncology of the American College of Radiology.

    Over the years at the University of Zürich, she went through all career steps from lecturer to full professor. She finally left University to become founder and owner of the animal oncology and imaging center (AOI Center). For more than 10 years she headed this specialty center, before taking the opportunity to work at SASH (Small animal specialist center) in Sydney. Since 2020 she is back in Switzerland and works as radiologist and consultant. Barbara has published numerous articles, presented at various international conferences, and helped to train many residents in radiology and radiation oncology.

    Full details
  • VetPD

    James Elliott
    BVM&S, CertSAM, Dipl.ECVIM-CA (Oncology), Dipl.ACVR (RO), MRCVS

    United Kingdom

    European Specialist in Veterinary Internal Medicine - Companion Animals (Oncology), American Specialist in Veterinary Radiology (Radiation Oncology)
    More Info

    James graduated from the University of Edinburgh and initially worked in small animal practice in England before completing a one year internship and residency in small animal oncology at the University of Liverpool. Here he underwent extensive training in the disciplines of medical oncology and radiotherapy. James holds the European College of Veterinary Internal Medicine (ECVIM) Diploma in Small Animal Oncology and is a recognised European Specialist in Small Animal Oncology and a Royal College of Veterinary Surgeons Recognised Specialist in Veterinary Oncology. He also holds the Royal College of Veterinary Surgeons Certificate in Small Animal Medicine.

    Subsequent to his training, James became a lecturer in oncology at the University of Liverpool where, in addition to running busy clinics seeing cancer patients, he was also responsible for teaching undergraduate students, postgraduates undergoing oncology training, and members of the nursing team. In 2013, James joined a large referral centre where he helped to develop the oncology service. James is a member of the Veterinary Cancer Society, the European Society of Veterinary Oncology and is a regular speaker to vets on oncology topics and has published on various subjects in veterinary literature, including blood biomarkers in certain cancers, chemotherapy for canine lymphoma and canine oral mast cell tumours.

    Having spent the last few years working in America in one of the most established veterinary radiation centres in the world, James is experienced in all aspects of modern veterinary radiation, clinical oncology and achieve high-level skills in treatment planning; particularly intensity-modulated radiation therapy, stereotactic radiosurgery and stereotactic body radiation therapy.

    James was awarded the 2019 ACVR resident prize for his research into radiation therapy for plasma cell tumours

    In his spare time James enjoys getting out and about in the countryside, music and travelling.

    Full details
 
Register